Taking into account the theory of One Health, we may address the following question: what are the programmatic benefits and financial savings of the Canadian Integrated Programme for Antimicrobial Resistance Surveillance (CIPARS) when compared to conventional single sector antimicrobial resistance surveillance systems?

Programmatic gains can be, for instance:

• an increased systems knowledge from being connected to all involved sectors,

• a possible accelerated time to detection of trends,

• opportunities to intervene in time, which potentially reduces future disease burden in humans and animals. There are many other gains that could be considered.

An integrated program such as CIPARS will clearly lead to financial savings when compared to single sector antimicrobial resistance surveillance. Savings will be expected from the focused design (reduced and optimal sample size), a centralised field and institutional organisation, centralised laboratory components, information technology infrastructure and data management, training, communication and evaluation.

What example do you have in mind?

1. How would you organise integrated antimicrobial resistance surveillance in your own country? Does it already exist?
2. What do you think are programmatic benefits and financial savings of integrated antimicrobial resistance surveillance when compared to conventional, ie non-integrated, single sector, human or animal antimicrobial resistance surveillance systems? How would you assess them quantitatively and qualitatively?

---

References

Zinsstag, J. et al. (2011). From ‘One Medicine’ to ‘One Health’ and Systemic Approaches to Health and Well-being, in: Preventive Veterinary Medicine 101, 148-156.

Lizenz